The present inventors carried out dedicated research to generate antibody constant regions with reduced Fc³ receptor-binding activity by altering amino acid sequences in the antibody constant region. As a result, the present inventors successfully identified novel constant region sequences with reduced Fc³ receptor-binding activity compared to conventional antibody constant regions.